Targeted Radionuclide Therapy Consortium (TRTC)

The inaugural Targeted Radionuclide Therapy Consortium (TRTC) will take place in Madison, WI this September! The TRTC is a three day meeting focused on fulfilling our mission: to advance science and educations in nuclear medicine for the benefit of society within the concept of personalized healthcare.

Registration is due by August 23rd.

Targeted Radionuclide Therapy (TRT) is a rapidly emerging field that integrates radiochemistry, radiology, radiation oncology, and medical physics. TRTC will explore these respective fields in four sessions as they relate to TRT in order to better understand the current status and future directions of TRT:

1. Radiochemistry, Isotopes, & Supply
2. Emerging Agents & Applications
3. Imaging & Advanced Dosimetry
4. Clinical Translation, Regulatory, & Reimbursement

Registration is free. Total attendance is capped at 150, including attendees from around the world. This relatively smaller meeting will provide a casual setting that will help facilitate discourse among attendees. Thanks to our gracious sponsors, the meeting is entirely free for attendees and speakers, outside of travel and lodging. There is no registration fee, and all meals and refreshments – including Wisconsin’s finest beer, wine, and cheese – are provided at no cost.

Agenda & Speakers

Register Now

If you have any questions, please do not hesitate to email Joseph Grudzinski, PhD and Justin Jeffery.